Bravo Pharma Officially Partners with G42 Healthcare to Spearhead the Field of Genomics

Abu Dhabi, UAE, April 5th, 2023, ZEXPRWIRE, World-leading healthcare specialists Bravo Pharma have officially entered a strategic partnership with the region’s pioneering AI-powered healthcare company G42 Healthcare. In addition to this partnership, Bravo Pharma has also organized and participated with G42 Healthcare in a Conference dedicated to Clinical Genomics, Proteomics and Somalogic at Republicans Oncology Centre Tashkent Uzbekistan, attended by doctors from various oncology regional hospitals and the specialists from G42 Healthcare Abu Dhabi, Dr. Azza Attia and Mohd Rafiq M Zuraiqi. 

Furthermore, they participated in the inaugural ceremony of the first Reference Oncology Diagnostic center which has been established by Bravo Pharma Group in association with Republicans Oncology Centre Tashkent Uzbekistan. The ceremony was attended by Indian Ambassador H.E Shri Manish Prabhat, Director Oncology Mirza Ghalib Tillyashaykhov and other office bearers.

G42 Healthcare, the leading Abu Dhabi-based health-tech company, aims to transform the traditional healthcare ecosystem across the region and beyond, by harnessing AI and advanced medical technologies. In line with its mission to unlock the potential of personalized and preventive care, G42 Healthcare has established Biogenix Labs, UAE’s first COVID-19 accredited large-scale throughput laboratory, launched IROS, the region’s first contract research organization for clinical research, and set up the Omics Centre of Excellence, the region’s largest and most technologically advanced Omics facility. 

For Bravo Pharma, this strategic partnership with G42 Healthcare signals an increased effort in creating AI-based health services across the region and beyond through best-in-class integrated and multidisciplinary care in Central Asia, Africa and India by building highly efficient clinical reporting systems using bioinformatics and AI. 

Bravo Pharma CMD Rakesh Pandey, a well-known entrepreneur and social philanthropist has been the center of the company’s operations on extending the field of genomics and pre diagnosis of solid cancer both geographically and research wise.

Regarding the collaboration, he stated, “For us, this partnership comes as a step closer to our mission of taking healthcare to the next level. As time and technology advance, we have the duty to provide everyone with the best and leading healthcare possible to ensure the highest quality of life for all. With G42 Healthcare’s AI development and our core new drug discovery cytogenetic, targeted therapy and advanced diagnostics competencies, we will be able to spearhead the region’s genome and health data computation processes.”

Kareem Shahin, Chief Business Officer, G42 Healthcare commented, “Joining hands with Bravo Pharma strengthens our unified vision for a more personalized, intelligent, and value-based healthcare model. The impactful collaboration will enable us to deploy our best-in-class sequencing technologies to provide clinical genomics sequencing services coupled with clinical reporting and bioinformatics to propel healthcare forward.”

About Bravo Pharma 

Bravo Pharma is a UK-based, global healthcare company, leading the field of genome sequencing solutions, advanced diagnostics, equipment and research. They utilize the world’s most modern and innovative technologies in drug development, targeted therapy, and non-invasive diagnostics to deliver the utmost quality of life to all. 

To learn more, visit https://www.bravopharma.com/ 

PR Contact

ZEX PR WIRE ™ 

[email protected]

The Post Bravo Pharma Officially Partners with G42 Healthcare to Spearhead the Field of Genomics first appeared on ZEX PR Wire

Information contained on this page is provided by an independent third-party content provider. Binary News Network and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact [email protected]

News

A Plethora of Benefits is Available with High risk merchant accounts from Premier One

The top-notch merchant account provider named Premier One Payments assures to provide a wide range of benefits along with the high risk merchant accounts...

Hartford-Based Luxury Clothing Store, One Foot Forward, Is Bringing An Element of Comfort to Premium Quality Clothing

“Our premium quality clothes are for fierce men and women who never look back,” Says One Foot Forward’s CEO Hartford, CT, 19th September 2022, ZEXPRWIRE, The sofa-to-street...

This Season Make Your Home More Lively with Kridovia Appliances

Kolkata, India, 3rd November 2022, ZEXPRWIRE, The craze of the festive season almost last over a week or so and we all know how...

Realty World Curri Properties Have Partnered with Gibraltar Builders to Help People Build Their Dream Homes

Brevard County’s leading real estate agency offers new construction homes for only $7,500 down by teaming up with Gibraltar Builders Brevard County, FL, 12th November...

Nanda and Associate Lawyers Helps with Inland and Outland Spousal Sponsorship Applications

Mississauga, ON, 2nd August 2022, ZEXPRWIRE, Nanda & Associate Lawyers has helped countless Canadians sponsor their partners. They guide their clients at every stage of the spousal...

What dropshipping supplier to use South Africa

Johannesburg, South Africa, 14th September 2022, ZEXPRWIRE, Dropshipping is a business model in which you sell products that are shipped directly from the supplier...

VF Agency Expands Beyond Cryptocurrency and Financial Services

Delaware, US, 5th April 2023, ZEXPRWIRE, VF Agency was founded in 2020 just as the Coronavirus pandemic was at its peak. It was a rough...

FXDX Launching on Optimism with $10bn Target After Unmatched $400m Volume on Algorand; In Partnership with Router Protocol

Tortola, British Virgin Islands, 22nd February 2023, ZEXPRWIRE, FXDX, a decentralized on-chain derivative exchange, has announced that it is expanding to Optimism, a leading layer 2...